⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REPL News
Replimune Group, Inc.
Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma
globenewswire.com
REPL
Bragar Eagel & Squire, P.C. is Investigating Replimune Group Inc. on Behalf of Replimune Stockholders and Encourages Investors to Contact the Firm
globenewswire.com
REPL
Bronstein, Gewirtz & Grossman, LLC Encourages Replimune Group Inc. (REPL) Investors to Inquire about Securities Investigation
accessnewswire.com
REPL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL
prnewswire.com
REPL
Form 8-K
sec.gov
REPL
REPL INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
globenewswire.com
REPL
Securities Fraud Investigation Into Replimune Group Inc. (REPL) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
businesswire.com
REPL
Replimune Group Inc. (REPL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
businesswire.com
REPL
Securities Fraud Investigation Into Replimune Group Inc. (REPL) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
businesswire.com
REPL
Replimune Group, Inc. (REPL) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Following FDA Briefing Document
globenewswire.com
REPL